Haselmann V, Schamberger C, Trifonova F, Ast V, Froelich M, Strauss M
Pract Lab Med. 2021; 26:e00236.
PMID: 34041343
PMC: 8141926.
DOI: 10.1016/j.plabm.2021.e00236.
Liberale G, Vankerckhove S, Bouazza F, Gomez Galdon M, Larsimont D, Moreau M
JMIR Res Protoc. 2020; 9(8):e17976.
PMID: 32554370
PMC: 7455862.
DOI: 10.2196/17976.
Moltara M, Novakovic S, Boc M, Bucic M, Rebersek M, Zadnik V
Radiol Oncol. 2018; 52(3):289-295.
PMID: 30210039
PMC: 6137366.
DOI: 10.2478/raon-2018-0017.
Perissinotti A, Rietbergen D, Vidal-Sicart S, Riera A, Olmos R
Melanoma Manag. 2018; 5(1):MMT06.
PMID: 30190932
PMC: 6122522.
DOI: 10.2217/mmt-2017-0022.
Krahenbuhl L, Goldinger S, Mangana J, Kerl K, Chevolet I, Brochez L
Neoplasia. 2018; 20(2):218-225.
PMID: 29331888
PMC: 5767907.
DOI: 10.1016/j.neo.2017.12.002.
Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison.
Quinn C, Ma Q, Kudlac A, Palmer S, Barber B, Zhao Z
Adv Ther. 2016; 34(2):495-512.
PMID: 28000169
PMC: 5331084.
DOI: 10.1007/s12325-016-0464-9.
Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma.
Hoeller C, Michielin O, Ascierto P, Szabo Z, Blank C
Cancer Immunol Immunother. 2016; 65(9):1015-34.
PMID: 27372293
PMC: 4995227.
DOI: 10.1007/s00262-016-1860-3.
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.
Ortega-Martinez I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, Cortes J, Garcia-Vazquez M
Int J Cancer. 2016; 139(7):1598-607.
PMID: 27216146
PMC: 5089559.
DOI: 10.1002/ijc.30202.
Economic burden of toxicities associated with treating metastatic melanoma in eight countries.
Wehler E, Zhao Z, Bilir S, Munakata J, Barber B
Eur J Health Econ. 2016; 18(1):49-58.
PMID: 26721505
PMC: 5209401.
DOI: 10.1007/s10198-015-0757-y.
Controversies in the diagnosis and treatment of early cutaneous melanoma.
Orzan O, Sandru A, Jecan C
J Med Life. 2015; 8(2):132-41.
PMID: 25866567
PMC: 4392104.
Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.
Berrocal A, Arance A, Lopez Martin J, Soriano V, Munoz E, Alonso L
Melanoma Res. 2014; 24(6):577-83.
PMID: 25046550
PMC: 4457498.
DOI: 10.1097/CMR.0000000000000108.
Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.
Forde P, Sadadcharam M, Hall L, O Donovan T, de Kruijf M, Byrne W
Cancer Gene Ther. 2014; 21(8):349-54.
PMID: 25034887
PMC: 4139741.
DOI: 10.1038/cgt.2014.35.
Report of a malignant melanoma arising in a small congenital nevus in a 3-year-old child.
Zangari A, Ilari M, Nino F, Ascanio M
J Indian Assoc Pediatr Surg. 2013; 18(4):165-6.
PMID: 24347875
PMC: 3853863.
DOI: 10.4103/0971-9261.121122.
Melanoma in primary care. The role of the general practitioner.
Buckley D, McMonagle C
Ir J Med Sci. 2013; 183(3):363-8.
PMID: 24091614
DOI: 10.1007/s11845-013-1021-z.
A Global Review of Melanoma Follow-up Guidelines.
Trotter S, Sroa N, Winkelmann R, Olencki T, Bechtel M
J Clin Aesthet Dermatol. 2013; 6(9):18-26.
PMID: 24062870
PMC: 3780800.
[Plantar ulcer in a multimorbid patient].
Bekou V, Baltisser I, Dummer R, Traber J
Chirurg. 2013; 84(3):222-4.
PMID: 23358712
DOI: 10.1007/s00104-012-2442-3.
Malignant melanoma.
Ortega Candil A, Rodriguez Rey C, Carreras Delgado J
ISRN Dermatol. 2012; 2012:308279.
PMID: 23259071
PMC: 3521489.
DOI: 10.5402/2012/308279.
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.
Dequen P, Lorigan P, Jansen J, van Baardewijk M, Ouwens M, Kotapati S
Oncologist. 2012; 17(11):1376-85.
PMID: 23024154
PMC: 3500357.
DOI: 10.1634/theoncologist.2011-0427.
Good clinical and radiological response to BRAF inhibitor in patient with metastatic thin melanoma.
Quintyne K, Baker S, Wallis F, Gupta R
BMJ Case Rep. 2012; 2012.
PMID: 22744255
PMC: 3448363.
DOI: 10.1136/bcr.11.2011.5202.
Asymptomatic melanoma of the superior cavo-atrial junction: The challenge of imaging.
Kruger T, Heuschmid M, Kurth R, Stock U, Wildhirt S
World J Cardiol. 2012; 4(1):20-2.
PMID: 22279601
PMC: 3262395.
DOI: 10.4330/wjc.v4.i1.20.
